{"uri": "eng-9426934", "concepts": [{"uri": "http://en.wikipedia.org/wiki/Acute_myeloid_leukemia", "type": "wiki", "score": 100, "label": {"eng": "Acute myeloid leukemia"}}, {"uri": "http://en.wikipedia.org/wiki/Clinical_trial", "type": "wiki", "score": 68, "label": {"eng": "Clinical trial"}}, {"uri": "http://en.wikipedia.org/wiki/Chief_executive_officer", "type": "wiki", "score": 60, "label": {"eng": "Chief executive officer"}}, {"uri": "http://en.wikipedia.org/wiki/Relapse", "type": "wiki", "score": 58, "label": {"eng": "Relapse"}}, {"uri": "http://en.wikipedia.org/wiki/Food_and_Drug_Administration", "type": "wiki", "score": 58, "label": {"eng": "Food and Drug Administration"}}, {"uri": "http://en.wikipedia.org/wiki/Cytarabine", "type": "wiki", "score": 57, "label": {"eng": "Cytarabine"}}, {"uri": "http://en.wikipedia.org/wiki/Anthracycline", "type": "wiki", "score": 55, "label": {"eng": "Anthracycline"}}, {"uri": "http://en.wikipedia.org/wiki/Targeted_therapy", "type": "wiki", "score": 53, "label": {"eng": "Targeted therapy"}}, {"uri": "http://en.wikipedia.org/wiki/Cardiotoxicity", "type": "wiki", "score": 51, "label": {"eng": "Cardiotoxicity"}}, {"uri": "http://en.wikipedia.org/wiki/Webcast", "type": "wiki", "score": 50, "label": {"eng": "Webcast"}}, {"uri": "http://en.wikipedia.org/wiki/Disease", "type": "wiki", "score": 49, "label": {"eng": "Disease"}}, {"uri": "http://en.wikipedia.org/wiki/U.S._Securities_and_Exchange_Commission", "type": "wiki", "score": 48, "label": {"eng": "U.S. Securities and Exchange Commission"}}, {"uri": "http://en.wikipedia.org/wiki/Chairperson", "type": "wiki", "score": 46, "label": {"eng": "Chairperson"}}, {"uri": "http://en.wikipedia.org/wiki/Mutation", "type": "wiki", "score": 45, "label": {"eng": "Mutation"}}, {"uri": "http://en.wikipedia.org/wiki/Lung", "type": "wiki", "score": 45, "label": {"eng": "Lung"}}, {"uri": "http://en.wikipedia.org/wiki/Pharmaceutical_industry", "type": "wiki", "score": 42, "label": {"eng": "Pharmaceutical industry"}}, {"uri": "http://en.wikipedia.org/wiki/Cancer", "type": "wiki", "score": 42, "label": {"eng": "Cancer"}}, {"uri": "http://en.wikipedia.org/wiki/Soft-tissue_sarcoma", "type": "wiki", "score": 41, "label": {"eng": "Soft-tissue sarcoma"}}, {"uri": "http://en.wikipedia.org/wiki/Virus", "type": "wiki", "score": 39, "label": {"eng": "Virus"}}, {"uri": "http://en.wikipedia.org/wiki/Nasdaq", "type": "wiki", "score": 38, "label": {"eng": "Nasdaq"}}, {"uri": "http://en.wikipedia.org/wiki/CRi", "type": "person", "score": 23, "label": {"eng": "CRi"}}, {"uri": "http://en.wikipedia.org/wiki/AbbVie_Inc.", "type": "org", "score": 13, "label": {"eng": "AbbVie Inc."}}, {"uri": "http://en.wikipedia.org/wiki/Europe", "type": "loc", "score": 7, "label": {"eng": "Europe"}, "location": null}], "eventDate": "2024-03-25", "totalArticleCount": 12, "title": {"eng": "Moleculin Biotech, Inc. (NASDAQ:MBRX) Q4 2023 Earnings Call Transcript"}, "summary": {"eng": "Moleculin Biotech, Inc. isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).\n\nOperator: Greetings, welcome to the Moleculin Biotech 2023 Year-End Conference Call and Webcast. [Operator Instructions] Please note, that this conference is being recorded. I'd now turn the conference over to Jenene Thomas, Investor Relations. Thank you. You may begin.\n\nJenene Thomas: Thank you, Gerald. Good morning, and welcome everyone. At this time, I woul"}, "location": null, "categories": [{"uri": "dmoz/Health/Specific_Substances/Tobacco", "label": "dmoz/Health/Specific Substances/Tobacco", "wgt": 100}, {"uri": "dmoz/Shopping/Health/Conditions_and_Diseases", "label": "dmoz/Shopping/Health/Conditions and Diseases", "wgt": 100}, {"uri": "dmoz/Health/Men's_Health/Conditions_and_Diseases", "label": "dmoz/Health/Men's Health/Conditions and Diseases", "wgt": 100}, {"uri": "news/Business", "label": "news/Business", "wgt": 85}], "articleCounts": {"eng": 12}, "sentiment": 0.3098039215686275, "wgt": 449020800, "relevance": 2}